Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Pros Regulatory News (GPM)

Share Price Information for Golden Pros (GPM)

Share Price is delayed by 15 minutes
Get Live Data
110.00    -3.50 (-3.08%)
Bid:
108.00
Ask:
112.00
Spread: 4.00 (3.704%)
Market Cap: £108.69m
GPM Live PriceLast checked at - London Stock Exchange

Intraday Golden Pros Share Chart

Board Changes and Director Declaration

26 Mar 2026 07:00

RNS Number : 1498Y
Golden Prospect Precious Metals Ltd
26 March 2026
 

26 March 2026

Golden Prospect Precious Metals Limited (the "Company" or "GPM")

 

Board Changes and Director Declaration

 

The Board of the Company is pleased to announce that Christopher Waldron has been appointed as a Non-Executive Director and member of GPM's Audit, Management Engagement, and Remuneration & Nomination Committees with effect from 26 March 2026.

Mr Waldron, aged 61, is a resident of Guernsey. He is Chair of Crystal Amber Fund Limited and a director of Bluefield Solar Income Fund as well as a number of unlisted companies. He has over 35 years' experience as an investment manager and until 2013 was Chief Executive of the Edmond de Rothschild Group in the Channel Islands. Mr Waldron previously held investment management positions with James Capel, Bank of Bermuda, the Jardine Matheson Group and Fortis. A graduate of the University of London and Cranfield University, he is a Fellow of the Chartered Institute of Securities and Investment.

The Board of Directors considers Mr Waldron to be independent on appointment per the AIC Corporate Governance Code.

Toby Birch, Chairman, commented:

"I am pleased to welcome Chris as an Independent Non-Executive Director of the Company. His extensive investment management experience and leadership roles within listed and unlisted companies will bring significant insight and depth to GPM's governance and strategic oversight."

Directors' Declarations Pursuant to Rule 6.4.8R of the UK Listing Rules

 

Mr Waldron is currently a director of the below public companies:

 

· Bluefield Solar Income Fund Ltd; and

· Crystal Amber Fund Limited.

 

Within the last five years, Mr Waldron has been but is no longer a director of the below public company:

· UK Mortgages Limited.

 

There are no further disclosures required under Rule 6.4.8R of the UK Listing Rules in respect of Mr Waldron.

 

 

Enquiries

 

Apex Fund and Corporate Services (Guernsey) Limited

James Taylor

 

+44 (0) 203 5303 600

GPPMCoSec@apexgroup.com

 

About Golden Prospect Precious Metals 

Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability in Guernsey on 16 October 2006. The Company's investment objective is to provide Shareholders with capital growth from a portfolio of companies involved in the precious metals sector. For the latest factsheet and other information, click here.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUPWUPQGMA
Date   Source Headline
5th May 202612:11 pmRNSNet Asset Value(s)
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20261:21 pmRNSNet Asset Value(s)
1st May 202612:00 pmRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 202612:41 pmRNSNet Asset Value(s)
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 202611:35 amRNSNet Asset Value(s)
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20261:33 pmRNSNet Asset Value(s)
28th Apr 202610:40 amRNSReplacement: Transaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 202612:14 pmRNSNet Asset Value(s)
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202612:40 pmRNSNet Asset Value(s)
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20261:46 pmRNSMonthly Investor Report - March 2026
23rd Apr 202612:43 pmRNSNet Asset Value(s)
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20262:44 pmRNSNet Asset Value(s)
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20263:45 pmRNSNet Asset Value(s)
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20261:45 pmRNSNet Asset Value(s)
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 202611:49 amRNSNet Asset Value(s)
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20261:15 pmRNSNet Asset Value(s)
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 202612:51 pmRNSNet Asset Value(s)
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202612:37 pmRNSNet Asset Value(s)
13th Apr 20262:12 pmRNSNet Asset Value(s)
13th Apr 20267:00 amRNSAnnual Report and Audited Financial Statements
10th Apr 20262:36 pmRNSNet Asset Value(s)
9th Apr 20262:48 pmRNSNet Asset Value(s)
8th Apr 20262:40 pmRNSNet Asset Value(s)
7th Apr 20262:18 pmRNSNet Asset Value(s)
2nd Apr 20267:00 amRNSNet Asset Value(s)
31st Mar 202612:35 pmRNSNet Asset Value(s)
30th Mar 202612:43 pmRNSNet Asset Value(s)
27th Mar 20261:32 pmRNSNet Asset Value(s)
26th Mar 20261:19 pmRNSNet Asset Value(s)
26th Mar 20267:00 amRNSUpdate Following Resignation of Portfolio Managers
26th Mar 20267:00 amRNSBoard Changes and Director Declaration
25th Mar 202611:49 amRNSNet Asset Value(s)
24th Mar 20261:30 pmRNSNet Asset Value(s)
23rd Mar 20264:00 pmRNSNet Asset Value(s)
20th Mar 202612:26 pmRNSNet Asset Value(s)
19th Mar 202611:54 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.